| Patents for C07D 307 - Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom (47,108) |
|---|
| 02/12/2004 | WO2004012496A2 Method for producing an avocado unsaponifiable rich in furan lipids |
| 02/12/2004 | WO2003049702A3 Vanilloid receptor ligands and their use in treatments |
| 02/12/2004 | WO2002076941A3 Histone deacetylase inhibitors |
| 02/12/2004 | WO2002058698A3 Malonyl-coa decarboxylase inhibitors useful as metabolic modulators |
| 02/12/2004 | US20040030181 Process for stereoselectively reducing 4-aryl-4-oxobutanoic acid derivatives |
| 02/12/2004 | US20040030163 Catalytic cyclization of maleic (acid or anhydride) to tetrahydrofuran; mixed oxide catalyst |
| 02/12/2004 | US20040030161 Useful as a monomer in the manufacture of polymers and copolymers, especially polyester polymers and copolymers |
| 02/12/2004 | US20040030156 Substituted amino-furan-2-yl-acetic acid and amino-thien-2-yl-acetic acid derivatives and their use in the treatment of migraine and pain |
| 02/12/2004 | US20040030135 Chemical intermediate for herbicide |
| 02/12/2004 | US20040030132 Anticancer agents; arterosclerosis; bone disorders; antiarthritic agents; vision defects |
| 02/12/2004 | US20040030131 Central nervous system disorders |
| 02/12/2004 | US20040029958 Treatment of neurotic disorders |
| 02/12/2004 | US20040029957 Treatment of neurotic disorders |
| 02/12/2004 | US20040029956 Central nervous system disorders; anxiolytic agents; administering escitalopram |
| 02/12/2004 | US20040029946 Topical applying |
| 02/12/2004 | US20040029945 Method of inhibiting matrix metalloproteinases |
| 02/12/2004 | US20040029939 Inhibitors of IMPDH enzyme |
| 02/12/2004 | US20040029932 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/12/2004 | US20040029862 Alzheimer's disease |
| 02/12/2004 | US20040029814 Cathepins inhibitor; antiinflammatory agents; antiarthritic agents |
| 02/12/2004 | US20040029771 Methods for treating diseases related to intraocular pressure |
| 02/12/2004 | US20040029769 Polyalklbicylic derivatives |
| 02/12/2004 | US20040029728 Hydrogenation catalyst containing copper oxide |
| 02/12/2004 | CA2494632A1 3-amino-2-hrydroxyalkanoic acids and their prodrugs |
| 02/12/2004 | CA2494404A1 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 02/12/2004 | CA2494139A1 Biaryl compounds having anti-infective activity |
| 02/11/2004 | EP1388539A2 Process for the preparation of 3-hydroxytetrahydrofuran |
| 02/11/2004 | EP1387833A1 Protease-inhibitors |
| 02/11/2004 | EP1387827A2 Synthesis of cyclopentadiene derivatives |
| 02/11/2004 | EP1224177B1 Process for preparing oxazolines from tetrahydrofurans |
| 02/11/2004 | CN1473814A Intemediate for preparing alkyl-dihalogeno phenyl substituted keto-enol |
| 02/11/2004 | CN1137889C Novel tricycloacylamide compound, its preparation method and medicinal composition containing them |
| 02/11/2004 | CN1137682C Therapeutic agents |
| 02/10/2004 | US6689901 Process and intermediates to prepare latanoprost |
| 02/10/2004 | US6689891 2-bromomethyl-6-methyl-benzoic acid and a process for the preparation thereof |
| 02/10/2004 | US6689808 Substituted phthalides, a process for their preparations and pharmaceutical compositions containing them |
| 02/10/2004 | CA2223600C Production of levulinic acid from carbohydrate-containing materials |
| 02/05/2004 | WO2004011450A1 Process for the preparation of 1-(3-dimethylaminopropyl) -1-(4-fluorophenyl) -1,3-dihydroisobenzofuran -5-carbonitrile |
| 02/05/2004 | WO2004011423A2 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 02/05/2004 | WO2004011418A1 3,4-di-substituted cyclobutene-1, 2-diones as cxc-chemokine receptor ligands |
| 02/05/2004 | WO2004011417A1 N-bisaryl- and n-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 02/05/2004 | WO2004011410A1 Chemical compounds |
| 02/05/2004 | WO2004010936A2 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 02/05/2004 | WO2003076388A3 Bis-aniline derivatives useful as potassium channels modulators |
| 02/05/2004 | WO2003075857A3 Amino-methyl substituted tetracycline compounds |
| 02/05/2004 | WO2003074475A3 Substituted aryl ketones |
| 02/05/2004 | WO2003063849A9 Medicinal composition for diagnosis, prevention, or therapy of multiple risk factor syndrome |
| 02/05/2004 | US20040024268 Process for catalytically producing organic substances by partial oxidation |
| 02/05/2004 | US20040024228 Such as 5-hydroxy-2,6-norbornanecarbolactone via cyclization of unsaturated carboxylic acids |
| 02/05/2004 | US20040024067 Deacetylase inhibitors |
| 02/05/2004 | US20040024066 E.g., N-(2-(Benzo(b)thiophen-5-ylmethanesulfonyl)-1-(3,4-dichloro- phenyl)- ethyl)-N-hydroxyformamide; gene expression inhibitors of s-CD23; autoimmune disease; antiallergens; matrix metalloprotease enzyme inhibitors |
| 02/05/2004 | US20040024059 Novel pleuromutilin derivatives |
| 02/05/2004 | US20040024056 Especially Cryptotanshinone and Dihydortanshinone; treatment of chronic hepatitis and hepatocirrhosis |
| 02/05/2004 | US20040024055 Compounds HNP-98701A (epi-manassantin A), HNP-98701B and HNP-98701C (manassantin A) as carcinostatis substances |
| 02/05/2004 | US20040024045 Glucagon antagonists/inverse agonists |
| 02/05/2004 | US20040024041 Dermal therapeutic system containing non-steroidal antiphlogistics with selective cox-2 inhibition |
| 02/05/2004 | US20040023999 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof |
| 02/05/2004 | US20040023930 Active ingredient combination having insecticidal and acaricidal characteristics |
| 02/05/2004 | US20040023806 Agrochemicals in agriculture for controlling acarids and insects and for preventing the infestation of crop plants by phytopathogenic fungi. |
| 02/05/2004 | US20040022923 Marine oils with reduced levels of contaminants |
| 02/05/2004 | DE10233738A1 Stable suspensions of carotenoids, retinoids and/or unsaturated fatty acids, useful as additives in food, feed, pharmaceutical or cosmetic preparations, containing insoluble ascorbate salt particles as antioxidant |
| 02/05/2004 | DE10231890A1 Verfahren zur Abtrennung von Ascorbinsäure aus einem polaren, Ascorbinsäure und 2-Keto-L-gulonsäure enthaltenden Lösungsmittel Process for the separation of ascorbic acid from a polar, ascorbic acid and 2-keto-L-gulonic acid solvent containing |
| 02/05/2004 | DE10231627A1 New 1-benzoyl-3-(heterocyclyl-phenyl)-urea derivatives, are glycogen phosphorylase a inhibitors useful e.g. for treating type II diabetes, dyslipidemia or arteriosclerosis |
| 02/05/2004 | DE10022829B4 p-Aminophenol-Derivate und diese Verbindungen enthaltende Haarfärbemittel p-aminophenol derivatives and compositions containing these compounds Hair dyes |
| 02/05/2004 | CA2495167A1 Structural carotenoid analogs for the inhibition and amelioration of disease |
| 02/05/2004 | CA2494668A1 Chemical compounds |
| 02/05/2004 | CA2493975A1 N-aryl-cycloalkylidenyl-alpha-hydroxy-and alpha-alkoxy acid amides |
| 02/05/2004 | CA2491733A1 Ppar alpha selective compounds for the treatment of dyslipidemia and other lipid disorders |
| 02/04/2004 | EP1385820A1 Anthranilic acid amides, method for the production thereof, their use as antiarrhythmia agents, and pharmaceutical preparations thereof |
| 02/04/2004 | EP1385816A1 Method for purifying an organic solvent for the purpose of absorption of maleic acid anhydride |
| 02/04/2004 | EP1385503A1 The use of enantiomeric pure escitalopram |
| 02/04/2004 | EP1309580A4 Continuous process for the production of optically pure (s)-beta-hydroxy-gamma-butyrolactone |
| 02/04/2004 | EP1042319B1 Dihydrobenzofurans |
| 02/04/2004 | EP0796256B1 Process for preparing ranitidine |
| 02/04/2004 | CN1137114C Aryl hydrazide compound with activity of inhibiting growth of mosqito larva |
| 02/04/2004 | CN1137113C Catalyst for liquid phase hydrogenation of furaldehyde to prepare furfuralcohol and its use |
| 02/04/2004 | CN1137112C Catalyst used in furfural gaseous phase hydrogenation to prepare furyl alcohol and its preparing method |
| 02/04/2004 | CN1137111C Catalyst for preparing gamma-butyrolactone and silvan and its use |
| 02/03/2004 | US6686502 Compounds and methods for treatment of asthma, allergy and inflammatory disorders |
| 02/03/2004 | US6686390 Compounds having antiinflamatory activity: process for their preparation and pharmaceutical compositions containing them |
| 02/03/2004 | US6686389 2,3-dihydrobenzofuran derivatives |
| 02/03/2004 | US6686386 Combating photoinduced or chronological ageing of skin with retenoic acid receptor agonist |
| 02/03/2004 | US6686353 Diarylalkyl cyclic diamine derivatives as chemokine receptor antagonists |
| 02/03/2004 | US6686350 Cell adhesion inhibitors |
| 02/03/2004 | US6685965 Process for stabilizing levogyre ascorbic acid (laa), a stable aqueous laa composition, a process for preparing a stable topical solution, an emulsion, a vitamin product, and a method for cosmetic, pharmaceutical or nutritional treatment |
| 01/29/2004 | WO2004009552A1 Phosphodiesterase 4 inhibitors, including n-substituted aniline and diphenylamine analogs |
| 01/29/2004 | WO2004009527A1 Materials and methods for treating hypercholesterolemia |
| 01/29/2004 | WO2004009236A1 Catalyst regeneration by treatment with an oxidizing agent |
| 01/29/2004 | WO2004009065A1 Hypoglycemic agent, liver protecting agent and anticancer agent containing lignans originating in hongdoushan |
| 01/29/2004 | WO2004009017A2 Modulators of the glucocorticoid receptor and method |
| 01/29/2004 | WO2003053971A8 Pyridoquinoxaline antivirals |
| 01/29/2004 | US20040019217 Dihydoxyhexanoic acid derivatives, their intermediates, and methods of making |
| 01/29/2004 | US20040019216 Copper-catalyzed formation of carbon-heteroatom and carbon-carbon bonds |
| 01/29/2004 | US20040019113 Phosphate transport inhibitors |
| 01/29/2004 | US20040019106 Cyano and carboxy derivatives of substituted styrenes; inhibitors of tumor necrosis factor alpha, nuclear factor kappa B, and phosphodiesterase |
| 01/29/2004 | US20040019103 Method of enhancing cellular production of molecular chaperon, hydroxylamine derivatives useful for enhancing the chaperon production and the preparation thereof |
| 01/29/2004 | US20040019039 Substituted piperazines and diazepanes |
| 01/29/2004 | US20040019038 Compounds useful as anti-inflammatory agents |
| 01/29/2004 | US20040018258 Process for obtaining a furan lipid-rich unsaponifiable material from avocado |
| 01/29/2004 | US20040018239 Pharmaceutical preparation containing copolyvidone |